Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02715609
Recruitment Status : Suspended (Waiting to see if a dose expansion phase will be added)
First Posted : March 22, 2016
Last Update Posted : October 9, 2018
Sponsor:
Collaborator:
University of Calgary
Information provided by (Responsible Party):
Washington University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : February 28, 2019
  Estimated Study Completion Date : February 28, 2022